EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nephroprotective Effect of Diosmin against Cisplatin-Induced Kidney Damage by Modulating IL-1β, IL-6, TNFα and Renal Oxidative Damage

Tarique Anwer iD, Saeed Alshahrani iD, Ahmad M H Somaili, Abdullah H Khubrani, Rayan A Ahmed iD, Abdulmajeed M Jali iD, Ayed Alshamrani, Hina Rashid, Yousra Nomeir, Mohammad Khalid, Mohammad Firoz Alam iD

Molecules · 2023

DOI: 10.3390/molecules28031302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Tarique Anwer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia. Hauptthemen laut MEDLINE: Diosmin, Kidney Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jazan University, Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (CP) is a platinum compound of the alkylating agent class that is used for the treatment of various types of cancer. However, CP treatments in cancer patients are accountable for nephrotoxicity, as it is a major adverse effect. Hence, this research study was proposed to investigate the nephroprotective effect of diosmin, a flavonoid glycoside of hesperidin derivatives against cisplatin-induced kidney damage. Wistar rats received a single intraperitoneal (i.p) injection of CP (7.5 mg/kg, i.p) to induce nephrotoxicity. The administration of CP significantly (p < 0.001) increased the markers of kidney function test (creatinine, blood urea nitrogen, and uric acid) and demonstrated histopathological changes in the kidney of the CP-treated nephrotoxic group. In addition, the CP-treated nephrotoxic group demonstrated a significant (p < 0.001) increase in lipid peroxidation (LPO) levels and depleted activities of reduced glutathione (GSH), glutathione peroxidase (GPx), glutathione reductase (GR), superoxide dismutase (SOD) and catalase (CAT).However, diosmin (100 and 200 mg/kg) treatments significantly reduced the elevated levels of kidney function test parameters and restored structural changes in the kidney (p < 0.001). The administration of diosmin (100 and 200 mg/kg) significantly (p < 0.001) reduced LPO levels, increased GSH content and showed improvements in the activities of GPx, GR, SOD and CAT. The markers of inflammatory cytokines such as IL-1β, IL-6 and TNFα significantly (p < 0.001) increased in the CP-treated nephrotoxic group, whereas diosmin (100 and 200 mg/kg) treatments significantly (p < 0.001) reduced the elevated levels of these cytokines. The findings of this research demonstrate the nephroprotective effect of diosmin against CP-induced kidney damage. Therefore, we conclude that diosmin may be used as a supplement in the management of nephrotoxicity associated with CP treatments in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiosminKidney DiseasesRatsAnimalsCisplatinInterleukin-6Tumor Necrosis Factor-alphaRats, WistarKidneyOxidative StressAntioxidantsCytokinesSuperoxide DismutaseGlutathione Peroxidase

Stichwörter der Autor:innen

cisplatindiosmininflammatory cytokineslipid peroxidationnephrotoxicity

Substanzen

CisplatinInterleukin-6DiosminTumor Necrosis Factor-alphaAntioxidantsCytokinesSuperoxide DismutaseGlutathione Peroxidase

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
  • Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.

ORCID-Profile: Tarique Anwer, Saeed Alshahrani, Rayan A Ahmed, Abdulmajeed M Jali, Mohammad Firoz Alam

Förderung

  • Jazan University
  • Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia

Zitieren

APA

Anwer, T., Alshahrani, S., Somaili, A. M. H., Khubrani, A. H., Ahmed, R. A., Jali, A. M., Alshamrani, A., Rashid, H., Nomeir, Y., Khalid, M., & Alam, M. F. (2023). Nephroprotective Effect of Diosmin against Cisplatin-Induced Kidney Damage by Modulating IL-1β, IL-6, TNFα and Renal Oxidative Damage. Molecules. https://doi.org/10.3390/molecules28031302

Vancouver

Anwer T, Alshahrani S, Somaili AMH, Khubrani AH, Ahmed RA, Jali AM, et al. Nephroprotective Effect of Diosmin against Cisplatin-Induced Kidney Damage by Modulating IL-1β, IL-6, TNFα and Renal Oxidative Damage. Molecules. 2023. doi:10.3390/molecules28031302

BibTeX
@article{Anwer2023,
  author = {Anwer, Tarique and Alshahrani, Saeed and Somaili, Ahmad M H and Khubrani, Abdullah H and Ahmed, Rayan A and Jali, Abdulmajeed M and Alshamrani, Ayed and Rashid, Hina and Nomeir, Yousra and Khalid, Mohammad and Alam, Mohammad Firoz},
  title = {Nephroprotective Effect of Diosmin against Cisplatin-Induced Kidney Damage by Modulating IL-1β, IL-6, TNFα and Renal Oxidative Damage},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28031302}
}
Kostenlos starten →